Plasma endothelin-1 correlated with NYHA class, exercise capacity, BNP, and predicted adverse outcomes in chronic heart failure, supporting its role as a complementary biomarker to natriuretic peptides.
Beyond BNPET-1 independently predicted adverse outcomes in heart failure even after accounting for BNP — it captures vascular disease that BNP doesn't measure
What the researchers found
Plasma ET-1 correlated with NYHA class, exercise capacity, and BNP in CHF patients, and independently predicted adverse outcomes, providing complementary prognostic information to natriuretic peptides.
Why it matters
ET-1 captures vascular dysfunction that BNP doesn't. Together, they provide a more complete picture of heart failure severity and prognosis than either alone.
How the study worked
Cross-sectional study measuring plasma ET-1, BNP, ANP, and clinical parameters (NYHA class, peak VO2, echocardiography) in chronic heart failure patients with outcome follow-up.
What this study cannot tell us
Cross-sectional with outcome follow-up. Specific ET-1 cutoffs for clinical decisions not established. ET-1 assay variability is a concern.
How to read the evidence
Moderate evidence from a clinical study with multi-parameter correlation and outcome prediction.
When this study was published
Published in 2003. Endothelin in heart failure is well-established, though endothelin antagonists have had mixed clinical results in chronic HF.
The bigger picture
Heart failure involves both cardiac pump failure (BNP) and vascular dysfunction (ET-1). Measuring both captures the full pathophysiology for optimal risk stratification.
Questions still open
- Should ET-1 be routinely measured alongside BNP in heart failure?
- Does ET-1-guided therapy improve outcomes?
- Can endothelin antagonists improve vascular dysfunction in heart failure?
Common questions
What does endothelin-1 tell us about heart failure?
Should this be part of routine testing?
Read the original research
Plasma endothelin-1 levels and clinical correlates in patients with chronic heart failure.
Journal of cardiac failure, 9(4), 318-24
Citation
Kinugawa, Toru; Kato, Masahiko; Ogino, Kazuhide; Osaki, Shuichi; Igawa, Osamu; Hisatome, Ichiro; Shigemasa, Chiaki. (2003). Plasma endothelin-1 levels and clinical correlates in patients with chronic heart failure.. Journal of cardiac failure, 9(4), 318-24.